EPS · actual vs est
Revenue · actual vs est
Summary
Generated 2025-05-13
Management highlights
- Strong momentum carried from 2024 into 2025 with Q1 revenue up 27% YOY and 81 systems shipped, up 42% YOY.
- Signed backlog and remaining performance obligation near $60 million. Commercial growth in the U.S. driven by adoption of Deep TMS for OCD, anxious depression, etc.
- Focus on strengthening customer base with multi-year agreements and elevating customer service. Scaling pay-per-use and lease-based models for recurring revenue.
- Technological and clinical differentiation with Deep TMS, with over 60% of OCD patients responding positively to therapy. Progress in trials for PTSD and MDD accelerated protocols.
- Strong gross margin of 75%, increased operating income and adjusted EBITDA margin, and positive cash flow from operations.
Segment performance
In the first quarter of 2025, BrainsWay generated $11.5 million in revenue, marking a 27% increase year-over-year. They shipped 81 Deep TMS systems, a 42% increase compared to Q1 2024. The backlog and remaining performance obligation totaled nearly $60 million. Gross profit for Q1 2025 was $8.6 million, resulting in a 75% gross margin. Revenue contribution from product segments is not explicitly broken down further in the transcript, but overall revenue growth and system shipments are highlighted as key performance indicators.
Guidance
- Reiterated full-year 2025 revenue guidance of $49 million to $51 million, representing a 20% to 24% growth over 2024.
- Anticipates operating income of 3% to 4% and adjusted EBITDA of 11% to 12% for full year 2025.
Risks
- Actively monitoring geopolitical, supply chain, and tariff policies, but currently does not see a material impact on gross margin for the current year.
Q&A highlights
Q: Steve Lichtman from Oppenheimer & Company asked about greenfield opportunity vs competitive conversions.
A: Hadar Levy responded that roughly 80% of new sales are from greenfield (new customers) and 20% from competitive conversions.
Q: Destiny from Ladenburg Thalmann asked about OCD coils shipped and TMS 360.
A: Hadar Levy said 57 OCD coils were shipped, bringing total to close to 850 globally, and discussed TMS 360 as a mix of new installations and upgrades depending on customer segmentation.
Q: Ram Selvaraju with H.C. Wainwright asked about geopolitical risk and stock repurchase.
A: Hadar Levy said they are monitoring geopolitical factors but see no material impact currently, and not considering a stock repurchase program at the moment, but will evaluate toward year-end after assessing opportunities.
Key numbers
Reported versus consensus
Earnings calendar feed
| Metric | Reported | Consensus | Delta | Prior year |
|---|---|---|---|---|
| EPS | — | — | — | — |
| Revenue | — | — | — | — |
Transcript
May 13, 2025Full transcript unavailable for redistribution
The structured summary above covers the available call sections. Full transcript text is not included on this page.
Continue exploring
Prior quarters
This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.